Form 8-K · Current report
CBRE Group 8-K, filed Oct 22, 2026
- Filed
- CIK
- 0001138118
- Accession no.
- 0001138118-26-000028
Summary
CBRE Group reported third-quarter 2026 revenue of $11.5 billion, up 13%, with GAAP EPS up 26% to $1.52 and core EPS up 28% to $2.05. Chair and CEO Bob Sulentic attributed the results to double-digit growth in both resilient and transactional businesses and continued progress in critical infrastructure services.
Key points
- Critical infrastructure services revenue rose 80%, driven by data center services and contributions from Pearce Services, acquired in November 2025.
- Global property sales revenue rose 28%, while global leasing revenue rose 6%; mortgage origination revenue edged up 1%.
- The loan servicing portfolio rose 8% during the quarter to more than $500 billion, and assets under management ended the quarter above $155 billion.
- Net leverage ratio was 1.36x with $5.0 billion of total liquidity, and the company repurchased nearly $1.2 billion of shares year-to-date.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On October 22, 2026, the Company issued a press release reporting its financial results for the third quarter of 2026. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained herein, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.